HCP
66
8
AAP
24
6
PAYX
53
2
INTU
56
-4
FLR
58
3
CF
57
-2
AA
48
-12
VTR
47
-7
SEE
56
6
EBAY
47
4
MAT
46
12
VIX
16
-13
VZ
50
3
AMG
54
2
SE
61
-4
DD
63
3
ZION
65
2
PVH
62
5
TSCO
49
5
RL
72
4
HCP
66
8
AAP
24
6
PAYX
53
2
INTU
56
-4
FLR
58
3
CF
57
-2
AA
48
-12
VTR
47
-7
SEE
56
6
EBAY
47
4
MAT
46
12
VIX
16
-13
VZ
50
3
AMG
54
2
SE
61
-4
DD
63
3
ZION
65
2
PVH
62
5
TSCO
49
5
RL
72
4
Financhill
Back

XTL Biopharmaceuticals Vs. Can Fite Biofarma Industry Stock Comparison

Sell
24

XTLB
XTL Biopharmaceuticals

Last Price:
1.71
Seasonality Move:
4.63%
Sell
42

CANF
Can Fite Biofarma

Last Price:
1.96
Seasonality Move:
-6.94%
Sell
24
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

  • The current XTL Biopharmaceuticals [XTLB] share price is $1.88. The Score for XTLB is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • XTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

  • The XTL Biopharmaceuticals share price today is $1.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

XTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 48.84 Sell
Chaikin Money Flow: 2641 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 2.01) Buy
Bollinger Bands (100): (1.99 - 2.75) Sell

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 35.7 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.96 - 2.5) Sell
Bollinger Bands (100): (1.98 - 3.06) Sell

XTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Buy
20-day SMA: 1.87 Buy
50-day SMA: 2.08 Sell
200-day SMA: 2.23 Sell
8-day EMA: 1.83 Buy
20-day EMA: 1.87 Buy
50-day EMA: 2.05 Sell
200-day EMA: 2.1 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2 Sell
20-day SMA: 2.11 Sell
50-day SMA: 2.21 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.01 Sell
20-day EMA: 2.11 Sell
50-day EMA: 2.24 Sell
200-day EMA: 2.45 Sell

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

XTL Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):